Gilder Gagnon Howe & Co’s CVS Health CVS Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,775	Closed	-$134K	–	414
2021 Q1	$134K	Buy	+1,775	New	+$129K	﹤0.01%	343

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gilder Gagnon Howe & Co's CVS Position: Q2 2021 in Review

Gilder Gagnon Howe & Co sold out of CVS Health (CVS) in Q2 2021, closing a stake of 1,775 shares — an estimated $134K sold.

Gilder Gagnon Howe & Co first reported a position in CVS in Q1 2021 and held it in 1 quarter. The position peaked at $134K in Q1 2021. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

Gilder Gagnon Howe & Co reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 1,775 CVS Health shares in Q2 2021, an estimated $134K.
Gilder Gagnon Howe & Co first reported a position in CVS Health in Q1 2021 and held it in 1 quarter.
Gilder Gagnon Howe & Co's CVS Health position peaked at $134K in Q1 2021.
2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2021, filed 16 Aug 2021.